A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT
In this first head-to-head study in the context of ART initiation, HIV RNA decline from baseline to week 12 was significantly more rapid for BIC/F/TAF compared with DRV/c/F/TAF.
Authors
- Merle Henderson (ORCID: https://orcid.org/0000-0003-3326-9674)
- Marta Boffito (ORCID: https://orcid.org/0000-0002-2213-1103)
- Akif A. Khawaja (ORCID: https://orcid.org/0000-0003-3267-0482)
- Ishrat Jahan (ORCID: https://orcid.org/0000-0002-7115-8468)
- Alfredo Soler Carracedo (ORCID: https://orcid.org/0000-0002-4561-9435)
- Amanda Clarke (ORCID: https://orcid.org/0000-0002-4632-2035)
- Arnold Xhikola
- Gary Whitlock (ORCID: https://orcid.org/0000-0003-3070-1281)
- Graham P. Taylor (ORCID: https://orcid.org/0000-0002-3773-2390)
- Ana Milinkovic (ORCID: https://orcid.org/0000-0002-7732-9168)
- Sarah Fidler (ORCID: https://orcid.org/0000-0003-1676-7583)
- Tanya Adams
- Su Jin Kang (ORCID: https://orcid.org/0000-0002-0369-2175)
Institutions
- Brighton and Sussex Medical School (GB)
- Chelsea and Westminster Hospital (GB)
- University Hospitals Sussex NHS Foundation Trust (GB)
- Imperial College London (GB)
Publication Details
- Journal
- HIV Research & Clinical Practice
- Published
- 2024-09-08
- DOI
- https://doi.org/10.1080/25787489.2024.2400453
- Citations
- 2
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- Gilead Sciences